--(BUSINESS WIRE)--Scleroderma Research Foundation (SRF) Board Member Bob Saget will host the 40th Cool Comedy – Hot Cuisine (CCHC) on Dec. 5th in New York City to support critical scleroderma research.
WHO: SRF is America’s first and leading nonprofit investor in scleroderma research. This year marks SRF’s 30th year funding the most promising medical research aimed at improved therapies and a cure.
- Hosted by Bob Saget with appearances by Michael Che, George Lopez, John Oliver, Jeff Ross and special musical guest Jackson Browne.
- Gourmet "Hot Cuisine" will be prepared by Top Chef Masters Susan Feniger and Mary Sue Milliken.
- The evening will honor Andrew and Violetta Merin and their 30-year commitment to a cure.
- The event will commemorate the SRF's history and achievements since its founding in 1987.
WHERE: Caroline’s on Broadway, New York City
WHEN: Tuesday, Dec. 5, 2017; cocktails at 6:30 PM; dinner at 7:30 PM
WHY: Money raised at CCHC funds groundbreaking research at top universities such as Johns Hopkins, Stanford, University of California, San Francisco and Yale. This past June, CCHC Los Angeles raised $1.4 million to fund life-saving research.
MORE INFORMATION ABOUT COOL COMEDY – HOT CUISINE
Cool Comedy – Hot Cuisine, sponsored by Actelion Pharmaceuticals and The Arthur Zimtbaum Foundation, will include a cocktail reception and a five-course dinner paired with wine from the Napa Valley. Celebrity chefs/restaurateurs Susan Feniger (also a SRF Board Member) and Mary Sue Milliken, Food Network’s Too Hot Tamales and both Bravo Top Chef Masters, will prepare the multi-course “Hot Cuisine.” A live auction will feature unique packages such as a first- class VIP trip to Las Vegas and a dinner prepared in your home by some of the country’s top chefs.
Tickets for the nearly sold out Cool Comedy – Hot Cuisine start at $500, with premium seats for $1,000 and $2,500; tables of six for $5,000 and tables of 10 are available for $10,000 and $25,000. All monies raised benefit the Scleroderma Research Foundation. Advance reservations are required. For more information, call (800) 441-CURE (2873) or visit www.SRFcchc.org.
MORE INFORMATION ABOUT SCLERODERMA
The word “scleroderma” is Greek for hard skin, the most visible characteristic of the disease. The disease is chronic, complex and debilitating, and often affects the internal organs such as the lungs, kidneys and gastrointestinal tract with life-threatening consequences. Peripheral vasculature damage due to scleroderma can result in loss of digits or limbs. The symptoms and severity of scleroderma vary from one person to another and the course of the disease is often unpredictable. Women are disproportionately affected with scleroderma (representing four out of five patients), usually in the prime of their lives, between the ages of 20 and 50; however, children and men of all ages and people across all ethnic boundaries can also be affected.
MORE INFORMATION ABOUT SCLERODERMA RESEARCH FOUNDATION
The SRF was established in San Francisco in 1987 by scleroderma patient, the late Sharon Monsky, with a passionate commitment that lives on today: to use the power of collaborative medical research to advance a cure for scleroderma. Chaired by Luke Evnin, Ph.D., managing partner of MPM Capital, a dedicated investor in life sciences, the SRF is enabling scientists from leading institutions across the nation and around the world to work together and develop an understanding of how the disease begins, how it progresses and what can be done to slow, halt or reverse the disease process.